TrialThe New England journal of medicine2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
Alexander M M Eggermont et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
596 papers cite itlatest 60 shown
this paperpooled ittrialcites it